Effects of an ashwagandha extract (KSM-66) on memory, attention, energy, and sleep in childre
- Conditions
- Cognitive performanceSleepEnergyAlternative and Complementary Medicine - Herbal remediesMental Health - Other mental health disordersNeurological - Other neurological disorders
- Registration Number
- ACTRN12621000656831
- Lead Sponsor
- Clinical Research Australia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
1. Parent-reported concerns in child’s attention, concentration, or memory
2. Child attends mainstream schooling and mainstream classing
3. Child is a healthy male or female aged between 6 and 12 years
4. Parent/legal guardian and child willing to provide a personally signed and dated informed consent indicating that they have been informed of all pertinent aspects of the trial.
5. Child willing and able to take prescribed supplements
6. Child’s BMI between 18 and 30 kg/m2
7. There is no plan for the child to commence new treatments over the study period
8. Parent and child fluent in English
1. Current or 12-month history in a child of any psychiatric disorder (including ADHD)
2. Child is currently taking pharmaceutical medications expected to affect behaviour and learning.
3. Current or history of clinically significant chronic medical condition in the child including but not limited to cardiovascular disease, organic brain disorder, seizure, or diabetes.
4. Any diagnosed learning disorder in the child
5. Child is experiencing exceptional social/family stressors (e.g., serious illness in the family, recent parental separation, etc).
6. Child is currently taking ashwagandha or other supplements that may affect cognition or sleep
7. Child has had a significant surgery over the last year
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method